Código QR

The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia

Nada Abu-Shraie,1 Afaf Al-Sheikh,1 Ibtisam Alharbi,2 Layla Alanizy,3 Mohammed Alshraim,1 Sahal I Khoshhal,4 Sarah A AlSalman,1 Ali Alrumaih,5 Ahmad Nader Fasseeh,6,7 Baher Elezbawy,6,8 Nada Abaza,6 Amr Semida,9 Marina George,10 Shireen Amin,9 Yousef Binamer11 1Ministry of National Guard-Health Affai...

Descrición completa

Gardado en:
Principais autores: Abu-Shraie N, Al-Sheikh A, Alharbi I, Alanizy L, Alshraim M, Khoshhal SI, AlSalman SA, Alrumaih A, Fasseeh AN, Elezbawy B, Abaza N, Semida A, George M, Amin S, Binamer Y
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2026-06-01
Series:ClinicoEconomics and Outcomes Research
Assuntos:
Upadacitinib
Cost-effectiveness
Budget impact
Saudi Arabia
Atopic dermatitis
Eczema
Acceso en liña:https://www.dovepress.com/the-cost-effectiveness-and-budget-impact-analysis-of-upadacitinib-for--peer-reviewed-fulltext-article-CEOR
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares